It has been asked throughout history: Haven't Native American tribes suffered enough? In September, the drug maker Allergan gave six patents for the drug Restasis to the upstate New York- based Saint Regis Mohawk Tribe, and paid the tribe $13.5 million to accept the patents and grant an exclusive license, also promising $15 million annually until t
The Federal Trade Commission issued the following news release:. The workshop, titled "Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics," will take place on November 8, 2017 at the FTC's Constitution Center Auditorium, 400 7th St., SW, Washington, DC. Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and
EVENT: Health and Human Services Department; Food and Drug Administration holds a workshop titled "Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access," to provide an overview of current regulatory science initiatives related to generic topical dermatological drug products.
Lamar Alexander, R- Tenn., issued the following opening statement at a hearing to examine what goes into price Americans pay when picking up their prescriptions:. "Not only was the request for these hearings bipartisan, but both this hearing and the first hearing were bipartisan, which means Senator Murray and I agreed on the witnesses. "Senator
Table of Contents Office of the Federal Register Agriculture Department SeeGrain Inspection, Packers and Stockyards Administration SeeRural Utilities Service NOTICES Agency Information Collection Activities; Proposals, Submissions, and Approvals: Fast Track Generic Clearance for Collection of Qualitative Feedback on Customer Satisfaction...
This Wednesday morning, DailyStockTracker.com looks at the performance of these four Drugs- Generic stocks: pSivida Corp., Tetraphase Pharmaceuticals Inc., Catalent Inc., and Lannett Co. Inc.. On Tuesday, shares in Watertown, Massachusetts headquartered pSivida Corp. recorded a trading volume of 671,482 shares, which was above their three months av
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Aprepitant Capsules USP, 40 mg, 80 mg, and 125 mg, the generic version of Emend Capsules, 40 mg, 80 mg, and 125 mg, of Merck Sharp& Dohme Corporation. According to IMS Health sales data for the 12 month period ending August 2017, th
On October 17, 2017, Neos Therapeutics, Inc. entered into a confidential Settlement and Licensing Agreement with Actavis Laboratoris FL, Inc.. This Agreement resolves all ongoing litigation involving the Company's patents protecting its Adzenys XR-ODT extended-release orally disintegrating tablets and Actavis's Abbreviated New Drug Application..
According to report published by Grand View Research, The Global Specialty Generics Market size was estimated at USD 30.0 billion in 2016. The Global Specialty Generics Market is expected to reach USD 174.9 billion by 2025, according to a new report by Grand View Research, Inc. Rise in demand for low-cost generic specialty drugs is a major factor e
The new report from MP Advisors titled "The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis" examines in detail the current treatment landscape and the outlook through 2021 of psoriasis treatment market facing the U.S. Biologics and the Biosimilars. The report is authored by a seasoned Analyst with experience of over 15
Upsher-Smith Laboratories, LLC today announced that it will be attending the American Academy of Neurology 2017 Fall Conference in Las Vegas, October 20-22, 2017. Upsher-Smith representatives will be available at booth #104 to discuss Qudexy XR extended-release capsules and Upsher-Smith's Access Pathways? Program. "Upsher-Smith is committed
Thank you Chairman Alexander and Ranking Member Murray for inviting me to testify today on a very important topic for our nation's patients, families, and their pharmacists: prescription drug prices. n1 It is an honor to be here. My name it Tom Menighan and I am the Executive Vice President and CEO of the American Pharmacists Association, or APhA.
The U.S. immunology drug market is expected to grow to $68 billion by 2023 due to the entry of new biosimilars and JAK inhibitorsVancouver, BC 10/17/2017 According to a new exciting and unprecedented 1000+ page report series on the U.S. market for immunology drugs by iData Research, the immunology market is facing strong competition and cost
BRIDGEWATER, N.J. and HAYWARD, Calif., Oct. 17, 2017/ PRNewswire/ Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. today announced that they have entered into a definitive business combination in an all-stock transaction. As a result of the transaction, Amneal Holdings members will own approximately 75% and Impax shareholders will own appr
AIDS Healthcare Foundation, the largest global AIDS organization and a vocal critic of runaway drug pricing and drug profiteering, today called on Gilead Sciences, Inc. to reduce the price of its tenofovir-based drug regimens including Truvada by as much as 90%. The California drug company has made billions off of sales of its tenofovir-based
Release date- 16102017- East Rutherford, NJ- Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced that it has made a number of investments, in both R&D and manufacturing capabilities to support the development and production of generic APIs, at its site in Paullo, M
Glenmark Pharmaceuticals has obtained final approval from the US FDA for. The tablets are generic equivalent to Merck Sharp and Dohme Corporation's Emend capsules. According to IMS health sales data for the 12 months ended Aug 2017, sales of Emend Capsules, 40, 80, and 125 milligram was about $64.9 million.
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Aprepitant Capsules Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Aprepitant Capsules USP, 40 mg, 80 mg, and 125 mg, the generic version of Emend Capsules, 40 m
Oct. 17 Impax Laboratories, with a location in Fort Washington, and Amneal Pharmaceuticals, based in Bridgewater, N.J., announced Tuesday they have agreed to merge in an all-stock deal that would create the nation's fifth-largest generics drug business by revenue. Impax shareholders will own 25 percent of the new publicly-traded company, and Amne
Release date- 16102017- TORONTO- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled and targeted release oral solid dosage drugs, announced today the closing of its previously announced registered direct offering consisting of 3,636,364 common..
Release date- 13102017- RALEIGH, N.C.- BioDelivery Sciences International, Inc., a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc., Actavis Laboratories UT, Inc. and Teva Pharmaceuticals Industries, Ltd. that
According to report published by Grand View Research, The Global Biosimilars Market was estimated at USD 3.1 billion in 2015. Biosimilars Market is expected to reach USD 41.7 billion by 2024, according to a new report by Grand View Research, Inc. The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 20
By a News Reporter-Staff News Editor at Mental Health Weekly Digest Breckenridge Pharmaceutical, Inc. announced it has acquired five Abbreviated New Drug Applications from Nostrum Laboratories Inc., a wholly owned subsidiary of Nostrum Pharmaceuticals, LLC. Three of the acquired assets are FDA approved and will be sold by Breckenridge under its l
Such was the case earlier this month, when the House Committee on Oversight and Government Reform requested a host of information from Allergan, a leading pharmaceutical company, pertaining to its novel arrangement with the Saint Regis Mohawk Tribe. Other observers, including legislative patent reform lobbyists such as Josh Landau of the Computer a
SUMMARY: The Food and Drug Administration is correcting a notice entitled " Department of Health and Human Services, Supply Service Center et al.; Withdrawal of Approval of 27 Abbreviated New Drug Applications" that appeared in the Federal Register of September 21, 2017. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Food and Drug